semaglutide mash approval Novo Nordisk's Wegovy Gains SEC for Treatment in India, ETPharma WEGOVY GETS APPROVAL: The weight-loss

It is possible that due to the long duration of a proposed trial and likely availability of new medications, that participants may decide to switch, especially if they are experiencing side effects

Pharmacology & Therapeutics, 113

APAC region is anticipated to grow at the highest CAGR during the forecast period owing to the growing incidence of type 2 diabetes and obesity, rapid urbanization and changing lifestyles

Vargason AM, Anselmo AC, Mitragotri S

Weight-Related Conditions People with obesity-related conditions, such as type 2 diabetes or metabolic health concerns, are also being studied to understand potential benefits